Literature DB >> 19455580

Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes.

Rochelle P Coelho1, Larra M Yuelling, Babette Fuss, Carmen Sato-Bigbee.   

Abstract

Neurotrophin-3 (NT-3) regulates oligodendrocyte (OLG) differentiation by mechanisms that remain poorly understood. Exposure of OLGs to NT-3 induces a significant increase in the levels of myelin basic protein (MBP). However, we found that this stimulation occurs in the absence of measurable effects on MBP gene promoter activation or mRNA expression, suggesting that NT-3 upregulates MBP protein expression by a posttranscriptional mechanism. Furthermore, NT-3 also causes an increase in the levels of myelin-associated glycoprotein (MAG) and myelin OLG glycoprotein (MOG), raising the possibility of a more general effect on myelin protein synthesis. Surprisingly, (35)S-methionine incorporation into total OLG proteins demonstrated a 50% increase in labeling following only a brief, 15-min treatment with NT-3. Such a remarkably fast response is unlikely due to transcriptional activation, reinforcing the possibility that NT-3 may play a crucial role in regulating protein expression by a posttranscriptional mechanism. In support of this idea, we found that NT-3 stimulates the phosphorylation of essential regulators of the initiation machinery, eukaryotic initiation factor 4E (eIF4E), and its inhibitory binding partner 4E binding protein 1 (4EBP1), two crucial players in controlling cap-dependent protein synthesis. This stimulation involves the activation of pathways mediated by ERK1/2 and PI3K/mTOR, implicating these two kinase systems as modulators of protein synthesis in developing OLGs. Altogether, these observations show for the first time that NT-3 has the capacity of targeting the translational machinery and suggest a potential stimulatory effect of this neurotrophin on myelination by direct action on protein translation in the OLGs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455580      PMCID: PMC4300950          DOI: 10.1002/glia.20888

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  74 in total

Review 1.  Developmental clustering of ion channels at and near the node of Ranvier.

Authors:  M N Rasband; J S Trimmer
Journal:  Dev Biol       Date:  2001-08-01       Impact factor: 3.582

Review 2.  The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.

Authors:  H S Keirstead; W F Blakemore
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

3.  Neurotrophin-3 promotes the survival of oligodendrocyte precursors in embryonic hippocampal cultures under chemically defined conditions.

Authors:  L Bertollini; M T Ciotti; E Cherubini; A Cattaneo
Journal:  Brain Res       Date:  1997-01-23       Impact factor: 3.252

4.  FGF modulates the PDGF-driven pathway of oligodendrocyte development.

Authors:  R D McKinnon; T Matsui; M Dubois-Dalcq; S A Aaronson
Journal:  Neuron       Date:  1990-11       Impact factor: 17.173

5.  NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.

Authors:  A Chang; A Nishiyama; J Peterson; J Prineas; B D Trapp
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

6.  Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors.

Authors:  Harsimran S Saini; Rochelle P Coelho; Sravan K Goparaju; Puneet S Jolly; Michael Maceyka; Sarah Spiegel; Carmen Sato-Bigbee
Journal:  J Neurochem       Date:  2005-12       Impact factor: 5.372

7.  Human oligodendrocyte precursor cells in vitro: phenotypic analysis and differential response to growth factors.

Authors:  Heather C Wilson; Claus Onischke; Cedric S Raine
Journal:  Glia       Date:  2003-11       Impact factor: 7.452

8.  NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo.

Authors:  S Kumar; M A Kahn; L Dinh; J de Vellis
Journal:  J Neurosci Res       Date:  1998-12-15       Impact factor: 4.164

9.  Remyelination protects axons from demyelination-associated axon degeneration.

Authors:  K A Irvine; W F Blakemore
Journal:  Brain       Date:  2008-05-18       Impact factor: 13.501

10.  Novel phosphorylation sites of eukaryotic initiation factor-4F and evidence that phosphorylation stabilizes interactions of the p25 and p220 subunits.

Authors:  X Bu; D W Haas; C H Hagedorn
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

View more
  13 in total

Review 1.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

2.  Conditional knockout of TOG results in CNS hypomyelination.

Authors:  Michael J Maggipinto; Joshay Ford; Kristine H Le; Jessica W Tutolo; Miki Furusho; John W Wizeman; Rashmi Bansal; Elisa Barbarese
Journal:  Glia       Date:  2017-01-07       Impact factor: 7.452

3.  Polycistronic Delivery of IL-10 and NT-3 Promotes Oligodendrocyte Myelination and Functional Recovery in a Mouse Spinal Cord Injury Model.

Authors:  Dominique R Smith; Courtney M Dumont; Jonghyuck Park; Andrew J Ciciriello; Amina Guo; Ravindra Tatineni; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2020-02-25       Impact factor: 3.845

4.  Good Things Come in Threes: Genetically Engineered Neural Stem Cells Mitigate Chronic CNS Autoimmunity.

Authors:  David Pleasure
Journal:  Mol Ther       Date:  2016-08       Impact factor: 11.454

5.  TGF-β1-miR-200a-PTEN induces epithelial-mesenchymal transition and fibrosis of pancreatic stellate cells.

Authors:  Min Xu; Guoying Wang; Hailang Zhou; Jing Cai; Ping Li; Meng Zhou; Ying Lu; Xiaomeng Jiang; Hongmei Huang; Youli Zhang; Aihua Gong
Journal:  Mol Cell Biochem       Date:  2017-03-09       Impact factor: 3.396

6.  The opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination.

Authors:  Allison A Vestal-Laborde; Andrew C Eschenroeder; John W Bigbee; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Dev Neurosci       Date:  2014-08-19       Impact factor: 2.984

Review 7.  Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.

Authors:  Li-Jin Chew; Cynthia A DeBoy
Journal:  Neuropharmacology       Date:  2015-06-24       Impact factor: 5.250

8.  Effect of Huazhuojiedu medicated serum on the proliferation and activation of hepatic stellate cells and the expression of PI3K and p-Akt in rats.

Authors:  Liang Kang; Yangang Wang; Mingxi Zhang; Runxue Sun; Yingying Lou; Ying Wang; Diangui Li
Journal:  Int J Clin Exp Med       Date:  2014-10-15

9.  PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics.

Authors:  Tyler Stevens; Katrin Sangkuhl; Jacob T Brown; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2019-08       Impact factor: 2.089

10.  Signaling mechanisms regulating myelination in the central nervous system.

Authors:  Jared T Ahrendsen; Wendy Macklin
Journal:  Neurosci Bull       Date:  2013-04-05       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.